Skip to main content

Want a detailed portfolio tracker?

Celularity (CELU) P/E (2020 - 2026)

Celularity (CELU) P/E from Sep 30, 2020 to Jul 21, 2026. The TTM Celularity (CELU) P/E is -0.23. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Celularity (CELU)

YearP/EChange
2026-0.23-27.03%
2025-0.32-59.76%
2024-0.79+211.68%
2023-0.25-97.64%
2022-10.76+51.84%
2021-7.09-29.48%
2020-10.05N/A

Comparison Celularity (CELU) P/E with competitors

Celularity (CELU) P/E is -0.23.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.73%
NBYStablecoin Development Corp0.00-101.85%
ENLVEnlivex Ltd0.07-132.17%
FGENFibroGen Inc0.24-203.24%
CHRSCoherus Biosciences Inc0.85-464.95%
FBIOFortress Biotech Inc0.95-508.17%
ORMPOramed Pharmaceuticals Inc1.50-746.45%
AGENAgenus Inc3.01-1394.41%
INVAInnoviva Inc3.15-1456.51%
VXRTVaxart Inc3.55-1626.71%
CRMDCorMedix Inc3.63-1660.56%
CVACCureVac N.V.4.45-2012.04%
GLPGGalapagos NV4.86-2189.76%
SRPTSarepta Therapeutics Inc4.88-2199.74%
ABEOAbeona Therapeutics Inc5.39-2417.11%
ABUSArbutus Biopharma Corp5.60-2506.62%
ZVRAZevra Therapeutics Inc5.89-2632.04%
SPROSpero Therapeutics Inc6.23-2778.79%
CGENCompugen Ltd6.31-2815.56%
RIGLRigel Pharmaceuticals6.87-3055.61%
SLXNSilexion Therapeutics Corp7.30-3237.97%
OMEROmeros Corporation9.26-4082.10%
AUPHAurinia Pharmaceuticals Inc9.58-4222.40%
PLXProtalix BioTherapeutics Inc10.89-4784.12%
ACADAcadia Pharmaceuticals Inc11.73-5144.33%
TBPHTheravance Biopharma Inc12.26-5373.84%
ADMAAdma Biologics Inc12.42-5440.93%
HRMYHarmony Biosciences Holdings Inc13.82-6043.94%
SABSSAB Biotherapeutics Inc14.14-6179.85%
NAGENiagen Bioscience Inc14.82-6473.14%
INCYIncyte Corp15.82-6905.14%
REGNRegeneron Pharmaceuticals Inc15.86-6919.81%
PBYIPuma Biotechnology Inc17.32-7547.34%
CPRXCatalyst Pharmaceuticals Inc17.44-7600.50%
EXELExelixis Inc17.54-7642.95%
TGTXTG Therapeutics Inc18.97-8257.14%
MDXGMimedx Group Inc20.55-8939.46%
XOMAXOMA Royalty Corp22.87-9938.47%
ARGXArgen X SE24.30-10550.64%
CTMXCytomX Therapeutics Inc24.82-10775.63%
XOMAOXOMA Royalty Corp25.34-11000.87%
HALOHalozyme Therapeutics Inc25.62-11120.83%
XOMAPXOMA Royalty Corp25.67-11140.79%
VRTXVertex Pharmaceuticals Inc27.99-12140.61%
RPRXRoyalty Pharma plc - Class A28.69-12438.59%
SLNOSoleno Therapeutics Inc29.02-12579.58%
ASNDAscendis Pharma A/S30.09-13039.88%
LGNDLigand Pharmaceuticals Inc - Class B37.91-16406.06%
APLSApellis Pharmaceuticals Inc39.02-16883.14%
BMRNBiomarin Pharmaceutical Inc42.21-18255.44%
KRYSKrystal Biotech Inc45.34-19602.36%
ONCBeiGene Ltd69.54-30009.56%
PHARPharming Group N.V.75.03-32368.73%
TECHBio-Techne Corp101.96-43952.62%
VCELVericel Corp109.92-47377.51%
ALNYAlnylam Pharmaceuticals Inc117.96-50837.16%
GMABGenmab140.29-60439.50%
TLXTelix Pharmaceuticals Ltd162.15-69842.44%
CORTCorcept Therapeutics Inc212.86-91650.68%